Biotech · Public company · San Diego, CA, US
Gossamer Bio, Inc.
Ticker GOSS · SEC CIK 0001728117
Track this companyFree. Adds Gossamer Bio, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials21 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availableNo recent cash burn filed
Pipeline4
- Gereic Dry Powder InhalerPhase 3 · Pulmonary Arterial HypertensionClinicalTrials.gov · fetched Nov 12, 2026
- SeralutinibPhase 3 · Pulmonary Arterial HypertensionClinicalTrials.gov · fetched Nov 12, 2026
- GB002 (seralutinib)Phase 2 · Pulmonary Arterial HypertensionClinicalTrials.gov · fetched Nov 12, 2026
- Generic Dry Powder InhalerPhase 2 · Pulmonary Arterial HypertensionClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)PHASE3 · RECRUITING · started Sep 3, 2024ClinicalTrials.gov NCT06274801 · fetched Nov 12, 2026
- Open-label Extension Study of GB002 in Adult Subjects With Pulmonary Arterial Hypertension (PAH)PHASE2 · TERMINATED · started Apr 5, 2021ClinicalTrials.gov NCT04816604 · fetched Nov 12, 2026
SEC filings12
- 8-K · 8-KSEC EDGAR · filed Nov 10, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Nov 10, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Oct 28, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Sep 28, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Sep 23, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Sep 16, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Sep 11, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Sep 9, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Sep 3, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Aug 26, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Aug 21, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Aug 13, 2026 · fetched Nov 12, 2026